Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


Real-time Estimate Quote. Real-time Estimate Tradegate - 08/03 03:58:00 pm
68.75 EUR   +0.81%
07/27COMPUGROUP MEDICAL : Receives a Buy rating from Warburg Research
07/26COMPUGROUP MEDICAL : Baader Bank maintains a Sell rating
07/26COMPUGROUP MEDICAL : Deutsche Bank gives a Buy rating
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical : expects revenues of EUR 1 billion in 2021 and invests in growth acceleration

12/07/2020 | 12:58pm EDT

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous/Development of Sales
CompuGroup Medical expects revenues of EUR 1 billion in 2021 and invests in growth acceleration

07.12.2020 / 18:56
The issuer is solely responsible for the content of this announcement.

  • CompuGroup Medical is planning for an approximately 20 % increase in revenue for 2021
  • Moderate adjusted EBITDA development expected for 2021
  • Organic growth is being accelerated
  • Significant increase in investment in new technologies and distribution capabilities to benefit from the rapidly growing trend towards digitization in the healthcare sector
  • Confirmation of 2020 guidance which had been raised in August

Koblenz. Today, CompuGroup Medical Management SE's Administrative Board resolved the budget plans for the financial year 2021. The Joint Committee of CompuGroup Medical SE & Co. KGaA will discuss this on December 14, 2020.

For the financial year 2021 very strong revenue growth of around 20 % is expected. This includes the two significant acquisitions in 2020, the acquisition of parts of the German and Spanish hospital information systems from Cerner, which was closed in July 2020, as well as the acquisition of US eMDs, Inc., which was announced on November 23, 2020. Effects for the Hospital Information Systems segment will occur mostly in Germany, and for the Ambulatory Information Systems business segment in the USA, with the US transaction still being subject to regulatory approvals. The strong revenue growth will also be driven by significantly higher organic growth of more than +5 % in the 2021 fiscal year.

Adjusted EBITDA for the financial year 2021 is expected to remain at a similar level as in 2020. This corresponds to an EBITDA margin in a range of 20 to 23 %. The reduction in operating margin is attributable to planned additional investments in new technologies and distribution to realize numerous growth opportunities arising for CGM from the fast progressing digitization of the healthcare system. The Managing Directors and the Administrative Board want to use these opportunities to enable strong organic growth and an attractive EBITDA margin also in the years following. As planned, the full guidance for the financial year 2021 will be published in the standard format on February 4, 2021.

CompuGroup Medical also confirms the guidance for the financial year 2020 which was raised in August. For the current year 2020, CompuGroup Medical is still expecting a revenue increase to a range of EUR 820 million to EUR 860 million and an adjusted EBITDA between EUR 205 million and EUR 220 million.

Frank Gotthardt, founder and CEO, said, "The rapidly progressing digitization in the healthcare sector is a blessing for humanity. This offers us great business opportunities and at the same time obliges us to seize them for the benefit of our customers, our employees and our shareholders. I am excited about the great growth opportunities for CGM. And I am delighted with the enthusiasm, skill and drive of our team in tackling the enormous challenges that lie ahead. I could not wish for a better setting to hand the leadership of this successful team over to Dr. Dirk Wössner and his colleagues on the Executive Board at the end of the year."

Explanations of the alternative financial ratios used (Alternative Performance Measures (APM)) can be found on the website of CompuGroup Medical SE & Co. KGaA in the annual report of CompuGroup Medical SE & Co. KGaA on pages 28 and 44 here.


About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of EUR 746 million in 2019, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.5 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverages among eHealth service providers. Approximately 6,300 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for media representatives:
Michael Franz
Head of Brand Communication
P +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100
E-mail: press@cgm.com

Contact for analysts and investors:
Claudia Thomé
Head of Investor Relations
P +49 (0) 261 8000-7030
F +49 (0) 261 8000-3200
E-mail: claudia.thome@cgm.com

07.12.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1153388

End of News DGAP News Service

1153388  07.12.2020 


ę EQS 2020
07/27COMPUGROUP MEDICAL : Receives a Buy rating from Warburg Research
07/26COMPUGROUP MEDICAL : Baader Bank maintains a Sell rating
07/26COMPUGROUP MEDICAL : Deutsche Bank gives a Buy rating
07/22COMPUGROUP MEDICAL : KoCoBox MED+ obtains approval as an electronic health recor..
07/22CompuGroup Medical Receives Kocobox MED+ Obtains Approval as an Electronic He..
07/19COMPUGROUP MEDICAL SE & CO. KGAA : Preliminary announcement of the publication o..
06/17COMPUGROUP MEDICAL SE & CO. KGAA : Release according to Article 40, Section 1 of..
06/14COMPUGROUP MEDICAL : Company Presentation June
06/08CompuGroup Medical SE & Co. KGaA acquired Meta IT GmbH.
06/02COMPUGROUP MEDICAL : Receives a Sell rating from Baader Bank
More news
Sales 2021 1 019 M 1 209 M 1 209 M
Net income 2021 79,5 M 94,3 M 94,3 M
Net Debt 2021 430 M 510 M 510 M
P/E ratio 2021 46,5x
Yield 2021 0,73%
Capitalization 3 651 M 4 328 M 4 330 M
EV / Sales 2021 4,00x
EV / Sales 2022 3,75x
Nbr of Employees 7 534
Free-Float 48,9%
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | COP | DE0005437305 | MarketScreener
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 68,75 €
Average target price 80,19 €
Spread / Average Target 16,6%
EPS Revisions
Managers and Directors
Dirk Woessner Chairman-Management Board & CEO
Michael Rauch Chief Financial Officer
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Hannes Reichl Managing Director-Clinical & Social Care
Sector and Competitors
1st jan.Capi. (M$)
SAP SE13.13%170 053
INTUIT INC.39.52%144 147
SERVICENOW, INC.6.22%115 844
DOCUSIGN, INC.32.75%57 496